XyloCor Therapeutics
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $69M
Investors
- 7
About XyloCor Therapeutics
Founded in 2013 and based in Pennsylvania, US, XyloCor Therapeutics, Inc. is a biopharmaceutical company that develops gene therapy for people with cardiovascular disease. Ronald Crystal and Todd Rosengart are the co-founders of the company. In January 2024, XyloCor Therapeutics, Inc. XyloCor's lead gene therapy product, XC001, is for individuals who have an inadequate endogenous self-revascularization response to ischemia. The XC001 and its prototype formulations are capable of robustly enhancing the blood supply to ischemic tissues in animal models and in clinical testing. The firm's secondary product, XC002, is for patients with cardiac tissue damage from heart attacks.
Who invested in XyloCor Therapeutics
7 investors across 3 rounds
See all investors in XyloCor Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about XyloCor Therapeutics
Who invested in XyloCor Therapeutics?
XyloCor Therapeutics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XyloCor Therapeutics raised?
XyloCor Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did XyloCor Therapeutics last raise money?
XyloCor Therapeutics's most recent round on record is a Series B, in Dec 2024.
What does XyloCor Therapeutics do?
Founded in 2013 and based in Pennsylvania, US, XyloCor Therapeutics, Inc.
Where is XyloCor Therapeutics headquartered?
XyloCor Therapeutics is headquartered in Wayne, US.
Which VCs invest in companies like XyloCor Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at XyloCor Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like XyloCor Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.